Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial

INTERVENTION: Experimental:Conventional treatment and Shenfu injection;control:Conventional treatment; CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: pneumonia severity index (PSI);Incidence of new organ dysfunction; SECONDARY OUTCOME: 28‐day prognosis;SOFA;Mechanical ventilation time;Length of stay in ICU ;Total hospital expenses;Dosage of vasoactive drugs; INCLUSION CRITERIA: 1. Confirmed and suspected cases of pneumonia from novel coronavirus infection; 2. Meet the diagnostic criteria for community ‐ acquired pneumonia; 3. Clinical classification is "heavy" or "critical"; 4. Aged 18 to 75 years; 5. Obtain informed consent.